Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$479,373,444
+$87,493,003 QoQ
Shares Held
1,904,997
+5.7% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#85
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $2,905,699,167 across 10 Drug Manufacturers - General names. ABBV ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
734,148 | $880,559,208 | |
| 2 | JNJ |
Johnson & Johnson
|
2,205,062 | $560,019,596 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,904,997 | $479,373,444 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,913,536 | $245,889,375 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,759,349 | $222,276,152 | |
| 6 | AMGN |
Amgen Inc
|
578,474 | $209,477,004 | |
| 7 | PFE |
Pfizer Inc
|
7,718,545 | $185,862,562 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,794,030 | $103,372,007 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,373,444 | 1,904,997 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $391,880,441 | 1,801,832 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $392,238,500 | 1,716,655 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $430,240,912 | 1,858,171 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $355,553,995 | 1,915,494 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $357,108,820 | 1,704,414 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $308,237,531 | 1,734,595 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $415,924,870 | 2,106,162 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $389,886,399 | 2,273,125 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $463,561,043 | 2,545,640 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $456,769,269 | 2,947,469 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $445,024,441 | 2,985,539 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $363,492,782 | 2,697,935 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $390,085,166 | 2,447,670 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $390,575,168 | 2,416,776 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $331,854,086 | 2,472,648 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $411,769,586 | 2,688,493 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $459,580,551 | 2,834,992 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $418,219,456 | 3,088,770 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $353,437,995 | 3,276,518 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $347,645,674 | 3,086,343 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $366,947,720 | 3,390,757 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $341,314,424 | 3,185,389 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $2,108,641 | 24,074 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $1,589,632 | 16,191 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $912,451 | 11,976 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||